LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1
- 25 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 29 (3-4), 277-291
- https://doi.org/10.1038/s41417-021-00306-8
Abstract
Long non-coding RNAs (lncRNAs) were recently recognized to vitally function in a variety of cancer cellular events, including epithelial-mesenchymal transition (EMT), invasion, and migration, particularly in ovarian cancer (OC). Herein, we sought to investigate the potential role of MAFG-AS1 in the malignant behaviors of OC cells. The binding affinity between MAFG-AS1, miR-339-5p, NFKB1 or IGF1 was characterized so as to identify the underlying mechanism of corresponding their interactions. We conducted MAFG-AS1 overexpression or knockdown along with NFKB1 and IGF1 silencing to examine their effects on the EMT, migration, and invasion of OC cells. Tumors were xenografted in nude mice to validate the in vitro findings. Our data showed significantly high expression pattern of MAFG-AS1 in the OC tissues and cells. Further mechanistic investigations revealed that MAFG-AS1 upregulated the IGF1 expression pattern through recruitment of NFKB1, whereas MAFG-AS1 upregulated the NFKB1 expression pattern through binding to miR-339-5p. Thus, MAFG-AS1 overexpression accelerated the EMT, invasion, and migration of OC cells, which could be annulled by silencing of IGF1 or NFKB1. Besides, our in vitro findings were successfully recapitulated in the xenograft mice. These results determined that MAFG-AS1 stimulated the OC malignant progression by upregulating the NFKB1-mediated IGF1 via miR-339-5p, thus highlighting a novel potential therapeutic target against OC.Keywords
This publication has 43 references indexed in Scilit:
- lncRNAs: Insights into their function and mechanics in underlying disordersMutation research. Reviews in mutation research, 2014
- NF-κB Affects Proliferation and Invasiveness of Breast Cancer Cells by Regulating CD44 ExpressionPLOS ONE, 2014
- Transdermal siRNA-TGFβ1-337 patch for hypertrophic scar treatmentMatrix Biology, 2013
- Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancerJournal of Gynecologic Oncology, 2013
- Capture of MicroRNA–Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor SignalingPLoS Genetics, 2011
- MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosisBMC Cancer, 2010
- Insulin-Like Growth Factor-I Regulates the Liver Microenvironment in Obese Mice and Promotes Liver MetastasisCancer Research, 2010
- MicroRNA‐9 inhibits ovarian cancer cell growth through regulation of NF‐κB1The FEBS Journal, 2009
- Neutralization of complement regulatory proteins CD55 and CD59 augments therapeutic effect of herceptin against lung carcinoma cellsOncology Reports, 2009
- Influence of microenvironments on microcirculation patterns and tumor invasion-related protein expression in melanomaOncology Reports, 2009